Cargando…
An autologous humanized patient-derived xenograft (PDX) model for evaluation of nivolumab immunotherapy in renal cell cancer: a case report
BACKGROUND: There is an unmet need for developing faithful animal models for preclinical evaluation of immunotherapy. The current approach to generate preclinical models for immunotherapy evaluation has been to transplant CD34(+) cells from umbilical cord blood into immune-deficient mice followed by...
Autores principales: | Kang, Yubin, Armstrong, Andrew J., Hsu, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659479/ https://www.ncbi.nlm.nih.gov/pubmed/36393918 http://dx.doi.org/10.21037/sci-2022-029 |
Ejemplares similares
-
Patient-derived xenograft (PDX) tumors increase growth rate with time
por: Pearson, Alexander T., et al.
Publicado: (2016) -
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
por: Abdolahi, Shahrokh, et al.
Publicado: (2022) -
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
por: Huang, Licai, et al.
Publicado: (2022) -
PDX Finder: A portal for patient-derived tumor xenograft model discovery
por: Conte, Nathalie, et al.
Publicado: (2019) -
Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
por: Okada, Seiji, et al.
Publicado: (2019)